Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To provide patients with severe hypercholesterolemia at risk for subsequent cardiovascular (CV) events and not adequately controlled with currently available lipid-modifying therapy (LMT) access to alirocumab ahead of commercial availability and to document the overall safety and tolerability of alirocumab in this patient population.
Critère d'inclusion
- Hypercholesterolemia